Vitamin D deficiency and diabetes

Biochemical Journal

Volumn 474, Issue 8, 2017, Pages 1321-1332

  Berridge, Michael J ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; DNA METHYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; VITAMIN D; INSULIN;

DIABETES MELLITUS; EPIGENETICS; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LANGERHANS CELL; METHYLATION; MITOCHONDRIAL RESPIRATION; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; VITAMIN D DEFICIENCY; ANIMAL; APOPTOSIS; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DIETARY SUPPLEMENT; DNA METHYLATION; EVIDENCE BASED MEDICINE; GENETIC EPIGENESIS; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; APOPTOSIS; CALCIUM SIGNALING; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DNA METHYLATION; EPIGENESIS, GENETIC; EVIDENCE-BASED MEDICINE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OXIDATIVE STRESS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85017647387     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BCJ20170042     Document Type: Review

References (173)

1. Scragg, R., Sowers, M. and Bell, C. (2004) Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27:2813-2818 doi:10.2337/diacare.27.12.2813
2. Mathieu, C., Gysemans, C., Giulietti, A. and Bouillon, R. (2005) Vitamin D and diabetes. Diabetologia 48:1247-1257 doi:10.1007/s00125-005-1802-7
3. Palomer, X., González-Clemente, J. M., Blanco-Vaca, F. and Mauricio, D. (2008) Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes. Metab. 10:185-197 doi:10.1111/j.1463-1326.2007.00710.x
4. Takiishi, T., Gysemans, C., Bouillon, R. and Mathieu, C. (2010) Vitamin D and diabetes. Endocrinol. Metab. Clin. North Am. 39:419-446 doi:10.1016/j.ecl.2010.02.013
5. Mitri, J., Muraru, M. D. and Pittas, A. G. (2011) Vitamin D and type 2 diabetes: a systematic review. Eur. J. Clin. Nutr. 65:1005-1015 doi:10.1038/ejcn. 2011.118
6. Wacker, M. and Holick, M. F. (2013) Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 5:111-148 doi:10.3390/nu5010111
7. Lips, P., Eekhoff, M., van Schoor, N., Oosterwerff, M., de Jongh, R., Krul-Poel, Y. et al. (2016) Vitamin D and type 2 diabetes. J. Steroid Biochem. Mol. Biol. pii: S0960-0760 (16) 30338-7. doi:10.1016/j.jsbmb.2016.11.021
8. Alam, U., Arul-Devah, V., Javed, S. and Malik, R. A. (2016) Vitamin D and diabetic complications: true or false prophet? Diabetes Ther. 7:11-26 doi:10.1007/s13300-016-0159-x
9. Wimalawansa, S. J. (2016) Associations of vitamin D with insulin resistance, obesity, type 2 diabetes, and metabolic syndrome. J. Steroid Biochem. Mol. Biol. pii: S0960-0760 (16) 30253-9. doi:10.1016/j.jsbmb.2016.09.017
10. Sentinelli, F., Bertoccini, L., Barchetta, I., Capoccia, D., Incani, M., Pani, M. G. et al. (2016) The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children. Nutr. Metab. Cardiovasc. Dis. 26:407-413 doi:10.1016/j.numecd.2016.02.004
11. 2+-dependent molecular mechanisms and the role of vitamin D status. Horm. Mol. Biol. Clin. Invest. 26:61-65 doi:10.1515/hmbci-2015-0069
12. Smotkin-Tangorra, M., Purushothaman, R., Gupta, A., Nejati, G., Anhalt, H. and Ten, S. (2007) Prevalence of vitamin D insufficiency in obese children and adolescents. J. Pediatr. Endocrinol. Metab. 20:817-823 doi:10.1515/JPEM.2007.20.7.817
13. Kumar, J., Muntner, P., Kaskel, F. J., Hailpern, S. M. and Melamed, M. L. (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics 124, e362-e370 doi:10.1542/peds.2009-0051
14. Oliveira, R. M., Novaes, J. F., Azeredo, L. M., Cândido, A. P. and Leite, I. C. (2014) Association of vitamin D insufficiency with adiposity and metabolic disorders in Brazilian adolescents. Public Health Nutr. 17:787-794 doi:10.1017/S1368980013001225
15. Harel, Z., Flanagan, P., Forcier, M. and Harel, D. (2011) Low vitamin D status among obese adolescents: prevalence and response to treatment. J. Adolesc. Health 48:448-452 doi:10.1016/j.jadohealth.2011.01.011
16. Vimaleswaran, K. S., Berry, D. J., Lu, C., Tikkanen, E., Pilz, S., Hiraki, L. T. et al. (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med. 10, e1001383 doi:10.1371/journal.pmed.1001383
17. Turer, C. B., Lin, H. and Flores, G. (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131, e152-e161 doi:10.1542/peds.2012-1711
18. Pereira-Santos, M., Costa, P. R. F., Assis, A. M. O., Santos, C. A. S. T. and Santos, D. B. (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes. Rev. 16:341-349 doi:10.1111/obr.12239
19. De Souza Silva, J. S., Pereira, S. E., Saboya Sobrinho, C. J. and Ramalho, A. (2016) Obesity, related diseases and their relationship with vitamin D deficiency in adolescents. Nutr. Hosp. 33:856-864 doi:10.20960/nh.381
20. Marcotorchino, J., Tourniaire, F., Astier, J., Karkeni, E., Canault, M., Amiot, M.-J. et al. (2014) Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J. Nutr. Biochem. 25:1077-1083 doi:10.1016/j.jnutbio.2014.05.010
21. Abbas, M. A. (2017) Physiological functions of vitamin D in adipose tissue. J. Steroid Biochem. Mol. Biol. 165(Pt B), 369-381 doi:10.1016/j.jsbmb. 2016.08.004
22. Kahn, S. E., Hull, R. L. and Utzschneider, K. M. (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846 doi:10.1038/nature05482
23. Newsholme, P., Cruzat, V. F., Keane, K. N., Carlessi, R. and de Bittencourt, Jr, P. I. H. (2016) Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem. J. 473:4527-4550 doi:10.1042/BCJ20160503C
24. Leahy, J. L. (2005) Pathogenesis of type 2 diabetes mellitus. Arch. Med. Res. 36:197-209 doi:10.1016/j.arcmed.2005.01.003
25. Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A. and Butler, P. C. (2003) β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110 doi:10.2337/diabetes.52.1.102
26. Chiu, K. C., Chu, A., Go, V. L. and Saad, M. F. (2004) Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 79:820-825 PMID:15113720
27. Mezza, T., Muscogiuri, G., Sorice, G. P., Prioletta, A., Salomone, E., Pontecorvi, A. et al. (2012) Vitamin D deficiency: a new risk factor for type 2 diabetes? Ann. Nutr. Metab. 61:337-348 doi:10.1159/000342771
28. Pilz, S., Kienreich, K., Rutters, F., de Jongh, R., van Ballegooijen, A. J., Grübler, M. et al. (2013) Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr. Diab. Rep. 13:261-270 doi:10.1007/s11892-012-0358-4
29. 3 modulates human adipocyte metabolism via nongenomic action. FASEB J. 15:2751-2753 doi:10.1096/fj.01-0584fje
30. 3 are mediated by the maintenance of the wingless-type MMTV integration site/β-catenin pathway. Int. J. Mol. Med. 30:1219-1224 doi:10.3892/ijmm.2012.1101
31. Sakuma, S., Fujisawa, J., Sumida, M., Tanigawa, M., Inoda, R., Sujihera, T. et al. (2012) The involvement of mitogen-activated protein kinases in the 1a, 25-dihydroxy-cholecalciferol-induced inhibition of adipocyte differentiation in vitro. J. Nutr. Sci. Vitaminol. 58:1-8 doi:10.3177/jnsv. 58.1
32. 3 inhibits uncoupling protein 2 expression in human adipocytes. FASEB J. 16:1808-1810 doi:10.1096/fj.02-0255fje
33. 3 in modulating adipocyte apoptosis. FASEB J. 18:1430-1432 doi:10.1096/fj.04-1971fje
34. Reaven, G. M. (1988) Role of insulin resistance in human disease. Diabetes 37:1595-1607 doi:10.2337/diab.37.12.1595
35. Qatanani, M. and Lazar, M. A. (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev. 21:1443-1455 doi:10.1101/gad.1550907
36. Goossens, G. H. (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol. Behav. 94:206-218 doi:10.1016/j.physbeh.2007.10.010
37. Saltiel, A. R. and Kahn, C. R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806 doi:10.1038/414799a
38. Savage, D. B., Petersen, K. F. and Shulman, G. I. (2007) Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87:507-520 doi:10.1152/physrev. 00024.2006
39. Lackey, D. E., Lazaro, R. G., Li, P., Johnson, A., Hernandez-Carretero, A., Weber, N. et al. (2016) The role of dietary fat in obesity-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. 311, E989-E997 doi:10.1152/ajpendo.00323.2016
40. Petersen, K. F. and Shulman, G. I. (2006) Etiology of insulin resistance. Am. J. Med. 119(Suppl. 1), S10-S16 doi:10.1016/j.amjmed.2006.01.009
41. 3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr. J. 47:383-391 doi:10.1507/endocrj.47.383
42. Maestro, B., Molero, S., Bajo, S., Dávila, N. and Calle, C. (2002) Transcriptional activation of the human insulin receptor gene by 1, 25-dihydroxyvitamin D (3). Cell Biochem. Funct. 20:227-232 doi:10.1002/cbf.951
43. Draznin, B., Sussman, K. E., Eckel, R. H., Kao, M., Yost, T. and Sherman, N. A. (1988) Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J. Clin. Invest. 82:1848-1852 doi:10.1172/JCI113801
44. Draznin, B., Lewis, D., Houlder, N., Sherman, N., Adamo, M., Garvey, W. T. et al. (1989) Mechanism of insulin resistance induced by sustained levels of cytosolic free calcium in rat adipocytes. Endocrinology 125:2341-2349 doi:10.1210/endo-125-5-2341
45. Reusch, J. E.-B., Begum, N., Sussman, K. E. and Draznin, B. (1991) Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes. Endocrinology 129:3269-3273 doi:10.1210/endo-129-6-3269
46. Kershaw, E. E. and Flier, J. S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89:2548-2556 doi:10.1210/jc.2004-0395
47. 3 upregulates leptin expression in mouse adipose tissue. J. Endocrinol. 216:265-271 doi:10.1530/JOE-12-0344
48. Walker, G. E., Ricotti, R., Roccio, M., Moia, S., Bellone, S., Prodam, F. et al. (2014) Pediatric obesity and vitamin D deficiency: a proteomic approach identifies multimeric adiponectin as a key link between these conditions. PLoS ONE 9, e83685 doi:10.1371/journal.pone.0083685
49. Rajala, M. W., Obici, S., Scherer, P. E., and Rossetti, L. (2003) Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest. 111:225-230 doi:10.1172/JCI16521
50. Rangwala, S. M., Rich, A. S., Rhoades, B., Shapiro, J. S., Obici, S., Rossetti, L. et al. (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes 53:1937-1941 doi:10.2337/diabetes.53.8.1937
51. Qi, Y., Nie, Z., Lee, Y.-S., Singhal, N. S., Scherer, P. E., Lazar, M. A. et al. (2006) Loss of resistin improves glucose homeostasis in leptin deficiency. Diabetes 55:3083-3090 doi:10.2337/db05-0615
52. Chandran, M., Phillips, S. A., Ciaraldi, T. and Henry, R. R. (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-2450 doi:10.2337/diacare.26.8.2442
53. Schwartz, M. W., Woods, S. C., Porte, Jr, D., Seeley, R. J. and Baskin, D. G. (2000) Central nervous system control of food intake. Nature 404:661-671 doi:10.1038/35007534
54. Frühbeck, G., Aguado, M. and Martinez, J. A. (1997) In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem. Biophys. Res. Commun. 240:590-594 doi:10.1006/bbrc.1997.7716
55. Frühbeck, G., Aguado, M., Gómez-Ambrosi, J. and Martínez, J. A. (1998) Lipolytic effect of in vivo leptin administration on adipocytes of lean and Ob/Ob mice, but not db/db mice. Biochem. Biophys. Res. Commun. 250:99-102 doi:10.1006/bbrc.1998.9277
56. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. and Spiegelman, B. M. (1995) Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415 doi:10.1172/JCI117936
57. Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J. et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830 doi:10.1172/JCI200319451
58. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., and Ferrante, Jr, A. W. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808 doi:10.1172/JCI200319246
59. Wellen, K. E. and Hotamisligil, G. S. (2005) Inflammation, stress, and diabetes. J. Clin. Invest. 115:1111-1119 doi:10.1172/JCI200525102
60. Shoelson, S. E., Lee, J. and Goldfine, A. B. (2006) Inflammation and insulin resistance. J. Clin. Invest. 116:1793-1801 doi:10.1172/JCI29069
61. Donath, M. Y. and Shoelson, S. E. (2011) Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11:98-107 doi:10.1038/nri2925
62. Wimalawansa, S. J. (2016) Vitamin D deficiency is a surrogate marker for visceral fat content, metabolic syndrome, type 2 diabetes, and future metabolic complications. J. Diabetes Metab. Disord. Control 3:00059 doi:10.15406/jdmdc.2016.03.00059
63. Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J. et al. (2005) Local and systemic insulin resistance from hepatic activation of IKKβ and NF-κB. Nat. Med. 11:183-190 doi:10.1038/nm1166
64. Marcotorchino, J., Gouranton, E., Romier, B., Tourniaire, F., Astier, J., Malezet, C. et al. (2012) Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol. Nutr. Food Res. 56:1771-1782 doi:10.1002/mnfr.201200383
65. 3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. PLoS ONE 8, e61707 doi:10.1371/journal.pone.0061707
66. 3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int. J. Obes. 37:357-365 doi:10.1038/ijo.2012.53
67. Lorente-Cebrián, S., Eriksson, A., Dunlop, T., Mejhert, N., Dahlman, I., Aström, G. et al. (2012) Differential effects of 1a, 25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human White adipocytes. Eur. J. Nutr. 51:335-342 doi:10.1007/s00394-011-0218-z
68. Rösen, P., Nawroth, P. P., King, G., Möller, W., Tritschler, H.-J. and Packer, L. (2001) The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17:189-212 doi:10.1002/dmrr.196
69. Evans, J. L., Goldfine, I. D., Maddux, B. A., and Grodsky, G. M. (2002) Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev. 23:599-622 doi:10.1210/er.2001-0039
70. Haber, C. A., Lam, T. K. T., Yu, Z., Gupta, N., Goh, T., Bogdanovic, E. et al. (2003) N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress. Am. J. Physiol. Endocrinol. Metab. 285, E744-E753 doi:10.1152/ajpendo.00355.2002
71. Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y. and Takahashi, H. (2003) Glucose toxicity in β-cells: type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes 52:581-587 doi:10.2337/diabetes.52.3.581
72. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625 doi:10.2337/diabetes.54.6.1615
73. Houstis, N., Rosen, E. D., and Lander, E. S. (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944-948 doi:10.1038/nature04634
74. Fridlyand, L. E. and Philipson, L. H. (2006) Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8:136-145 doi:10.1111/j.1463-1326.2005.00496.x
75. Wright, E., Scism-Bacon, J. L. and Glass, L. C. (2006) Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia. Int. J. Clin. Pract. 60:308-314 doi:10.1111/j.1368-5031.2006.00825.x
76. Robertson, R. P., Zhou, H., Zhang, T. and Harmon, J. S. (2007) Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem. Biophys. 48:139-146 doi:10.1007/s12013-007-0026-5
77. Manucha, W., Ritchie, B. and Ferder, L. (2015) Hypertension and insulin resistance: implications of mitochondrial dysfunction. Curr. Hypertens. Rep. 17:504 doi:10.1007/s11906-014-0504-2
78. Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J. et al. (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer's disease. Mediators Inflamm. 2015:17 doi:10.1155/2015/105828
79. Carlsson, C., Håkan Borg, L. A. and Welsh, N. (1999) Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140:3422-3428 doi:10.1210/endo.140.8.6908
80. Rao, M. S. and Reddy, J. K. (2001) Peroxisomal β-oxidation and steatohepatitis. Semin. Liver Dis. 21:43-56 doi:10.1055/s-2001-12928
81. 3 modulation of adipocyte reactive oxygen species production. Obesity 15:1944-1953 doi:10.1038/oby.2007.232
82. Berridge, M. J. (2015) Vitamin D: a custodian of cell signalling stability in health and disease. Biochem. Soc. Trans. 43:349-358 doi:10.1042/BST20140279
83. Berridge, M. J. (2015) Vitamin D cell signalling in health and disease. Biochem. Biophys. Res. Commun. 460:53-71 doi:10.1016/j.bbrc.2015.01.008
84. Alam, F., Islam, M., Gan, S., Mohamed, M. and Sasongko, T. (2016) DNA methylation: an epigenetic insight into type 2 diabetes mellitus. Curr. Pharm. Des. 22:4398-4419 doi:10.2174/1381612822666160527111152
85. Karachanak-Yankova, S., Dimova, R., Nikolova, D., Nesheva, D., Koprinarova, M., Maslyankov, S. et al. (2015) Epigenetic alterations in patients with type 2 diabetes mellitus. Balkan J. Med. Genet. 18:15-24 doi:10.1515/bjmg-2015-0081
86. Wahl, S., Drong, A., Lehne, B., Loh, M., Scott, W. R., Kunze, S. et al. (2017) Epigenome-wide association study of body mass index, and adverse outcomes of adiposity. Nature 541:81-86 doi:10.1038/nature20784
87. Baccarelli, A. and Bollati, V. (2009) Epigenetics and environmental chemicals. Curr. Opin. Pediatr. 21:243-251 doi:10.1097/MOP.0b013e32832925cc
88. Pereira, F., Barbáchano, A., Singh, P. K., Campbell, M. J., Muñoz, A. and Larriba, M. J. (2012) Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle 11:1081-1089 doi:10.4161/cc.11.6.19508
89. Kato, T. (2007) Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. CNS Drugs 21:1-11 doi:10.2165/00023210-200721010-00001
90. Andreazza, A. C., Shao, L., Wang, J.-F. and Young, L. T. (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch. Gen. Psychiatry 67:360-368 doi:10.1001/archgenpsychiatry.2010.22
91. Jou, S. H., Chiu, N. Y. and Liu, C. S. (2009) Mitochondrial dysfunction and psychiatric disorders. Chang. Gung. Med. J. 32:370-379 PMID:19664343
92. Clay, H. B., Sillivan, S. and Konradi, C. (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 29:311-324 doi:10.1016/j.ijdevneu.2010.08.007
93. Andreazza, A. C., Wang, J.-F., Salmasi, F., Shao, L. and Young, L. T. (2013) Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J. Neurochem. 127:552-561 doi:10.1111/jnc.12316
94. Callaly, E., Walder, K., Morris, G., Maes, M., Debnath, M. and Berk, M. (2015) Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy. Mini. Rev. Med. Chem. 15:355-365 doi:10.2174/1389557515666150324122026
95. Morris, G. and Berk, M. (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med. 13:68 doi:10. 1186/s12916-015-0310-y
96. Bansal, Y. and Kuhad, A. (2016) Mitochondrial dysfunction in depression. Curr. Neuropharmacol. 14:610-618 doi:10.2174/1570159X14666160229114755
97. Bouillon, R. and Verstuyf, A. (2013) Vitamin, D, mitochondria, and muscle. J. Clin. Endocrinol. Metab. 98:961-963 doi:10.1210/jc.2013-1352
98. Sinha, A., Hollingsworth, K. G., Ball, S. and Cheetham, T. (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J. Clin. Endocrinol. Metab. 98, E509-E513 doi:10.1210/jc.2012-3592
99. 3 regulates mitochondrial oxygen consumption and dynamics in human skeletal muscle cells. J. Biol. Chem. 291:1514-1528 doi:10.1074/jbc. M115.684399
100. Consiglio, M., Viano, M., Casarin, S., Castagnoli, C., Pescarmona, G. and Silvagno, F. (2015) Mitochondrial and lipogenic effects of vitamin D on differentiating and proliferating human keratinocytes. Exp. Dermatol. 24:748-753 doi:10.1111/exd.12761
101. Scaini, G., Rezin, G. T., Carvalho, A. F., Streck, E. L., Berk, M. and Quevedo, J. (2016) Mitochondrial dysfunction in bipolar disorder: evidence, pathophysiology and translational implications. Neurosci. Biobehav. Rev. 68:694-713 doi:10.1016/j.neubiorev. 2016.06.040
102. Kim, H. K., Andreazza, A. C., Yeung, P. Y., Isaacs-Trepanier, C. and Young, L. T. (2014) Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J. Psychiatry Neurosci. 39:276-285 doi:10.1503/jpn. 130155
103. Lowell, B. B., and Shulman, G. I. (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387 doi:10.1126/science.1104343
104. Calton, E. K., Keane, K. N. and Soares, M. J. (2015) The potential regulatory role of vitamin D in the bioenergetics of inflammation. Curr. Opin. Clin. Nutr. Metab. Care 18:367-373 doi:10.1097/MCO.0000000000000186
105. Silvagno, F., De Vivo, E., Attanasio, A., Gallo, V., Mazzucco, G. and Pescarmona, G. (2010) Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS ONE 5, e8670 doi:10.1371/journal.pone.0008670
106. Silvagno, F., Consiglio, M., Foglizzo, V., Destefanis, M. and Pescarmona, G. (2013) Mitochondrial translocation of vitamin D receptor is mediated by the permeability transition pore in human keratinocyte cell line. PLoS ONE 8, e54716 doi:10.1371/journal.pone.0054716
107. Fu, Z., Gilbert, E. R. and Liu, D. (2013) Regulation of insulin synthesis and secretion and pancreatic beta-cell dysfunction in diabetes. Curr. Diabetes Rev. 9:25-53 doi:10.2174/157339913804143225
108. Nicholls, D. G. (2016) The pancreatic β-cell: a bioenergetic perspective. Physiol. Rev. 96:1385-1447 doi:10.1152/physrev. 00009.2016
109. Gilon, P., Chae, H.-Y., Rutter, G. A. and Ravier, M. A. (2014) Calcium signaling in pancreatic β-cells in health and in type 2 diabetes. Cell Calcium 56:340-361 doi:10.1016/j.ceca.2014.09.001
110. 2+ in the pancreatic β-cell. Biochem. Biophys. Res. Commun. 151:1299-1304 doi:10.1016/S0006-291X (88) 80503-5
111. 2+ oscillations in pancreatic beta cells. Diabete. Metab. 24:30-36 PMID:9534006
112. Soria, B. and Martin, F. (1998) Cytosolic calcium oscillations and insulin release in pancreatic islets of Langerhans. Diabetes Metab. 24:37-40 PMID:9534007
113. Rodriguez-Diaz, R., Dando, R., Jacques-Silva, M. C., Fachado, A., Molina, J., Abdulreda, M. H. et al. (2011) Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat. Med. 17:888-892 doi:10.1038/nm.2371
114. Barker, C. J., Leibiger, I. B. and Berggren, P.-O. (2013) The pancreatic islet as a signaling hub. Adv. Biol. Regul. 53:156-163 doi:10.1016/j.jbior.2012. 09.011
115. Gilon, P. and Henquin, J.-C. (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr. Rev. 22:565-604 doi:10.1210/edrv. 22.5.0440
116. Barker, C. J. and Berggren, P.-O. (2013) New horizons in cellular regulation by inositol polyphosphates: insights from the pancreatic β-cell. Pharmacol. Rev. 65:641-669 doi:10.1124/pr.112.006775
117. Molina, J., Rodriguez-Diaz, R., Fachado, A., Jacques-Silva, M. C., Berggren, P.-O. and Caicedo, A. (2014) Control of insulin secretion by cholinergic signaling in the human pancreatic islet. Diabetes 63:2714-2726 doi:10.2337/db13-1371
118. Guo, Y., Traurig, M., Ma, L., Kobes, S., Harper, I., Infante, A. M. et al. (2006) CHRM3 gene variation is associated with decreased acute insulin secretion and increased risk for early-onset type 2 diabetes in Pima Indians. Diabetes 55:3625-3629 doi:10.2337/db06-0379
119. Ye, R., Ni, M., Wang, M., Luo, S., Zhu, G., Chow, R. H. et al. (2011) Inositol 1, 4, 5-trisphosphate receptor 1 mutation perturbs glucose homeostasis and enhances susceptibility to diet-induced diabetes. J. Endocrinol. 210:209-217 doi:10.1530/JOE-11-0012
120. Greene, D. A., Lattimer-Greene, S., and Sima, A. A. (1989) Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Crit. Rev. Neurobiol. 5:143-219 PMID:2561904
121. Berridge, M. J., Downes, C. P. and Hanley, M. R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59:411-419 doi:10. 1016/0092-8674 (89) 90026-3
122. Mancini, A. D. and Poitout, V. (2013) The fatty acid receptor FFA1/GPR40 a decade later: how much do we know? Trends Endocrinol. Metab. 24:398-407 doi:10.1016/j.tem.2013.03.003
123. Gautam, D., Han, S.-J., Hamdan, F. F., Jeon, J., Li, B., Li, J. H. et al. (2006) A critical role for β cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Cell Metab. 3:449-461 doi:10.1016/j.cmet.2006.04.009
124. 2+ signaling, and insulin secretion in the anx7 (+/-) knockout mouse. Proc. Natl Acad. Sci. U. S. A. 96:13783-13788 doi:10.1073/pnas.96.24. 13783
125. Littorin, B., Blom, P., Schölin, A., Arnqvist, H. J., Blohmé, G., Bolinder, J. et al. (2006) Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49:2847-2852 doi:10.1007/s00125-006-0426-x
126. Sung, C.-C., Liao, M.-T., Lu, K.-C. and Wu, C.-C. (2012) Role of vitamin D in insulin resistance. J. Biomed. Biotechnol. 2012:11 doi:10.1155/2012/634195
127. Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R. and Virtanen, S. M. (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358:1500-1503 doi:10.1016/S0140-6736 (01) 06580-1
128. 3 down-modulates the production of proinflammatory cytokines and nitric oxide and enhances the phosphorylation of monocyte-expressed STAT6 at the recent-onset type 1 diabetes. Immunol. Lett. 179:122-130 doi:10.1016/j.imlet.2016.10.002
129. Khaldi, M. Z., Guiot, Y., Gilon, P., Henquin, J. C. and Jonas, J. C. (2004) Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am. J. Physiol. Endocrinol. Metab. 287, E207-E217 doi:10.1152/ajpendo.00426.2003
130. Prentki, M. and Nolan, C. J. (2006) Islet β-cell failure in type 2 diabetes. J. Clin. Invest. 116:1802-1812 doi:10.1172/JCI29103
131. Bensellam, M., Laybutt, D. R. and Jonas, J.-C. (2012) The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Mol. Cell. Endocrinol. 364:1-27 doi:10.1016/j.mce.2012.08.003
132. Guerrero-Hernandez, A. and Verkhratsky, A. (2014) Calcium signalling in diabetes. Cell Calcium 56:297-301 doi:10.1016/j.ceca.2014.08.009
133. 2+]i abnormalities in human pancreatic islets: important role of overstimulation. Diabetes 49:1840-1848 doi:10.2337/diabetes.49.11.1840
134. Grill, V. and Björklund, A. (2001) Overstimulation and beta-cell function. Diabetes 50(Suppl 1), S122-S124 doi:10.2337/diabetes.50.2007. S122
135. 2+ channel expression in hippocampal neurons. J. Neurosci. 21:98-108 PMID:11150325
136. Gezen-Ak, D., Dursun, E. Yilmazer, S. and van der Brug, M. (2011) The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons. PLoS ONE 6, e17553 doi:10.1371/journal.pone.0017553
137. de Viragh, P. A., Haglid, K. G. and Celio, M. R. (1989) Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc. Natl Acad. Sci. U. S. A. 86:3887-3890 doi:10.1073/pnas.86.10.3887
138. Bouillon, R., Carmeliet, G., Verlinden, L., van Etten, E., Verstuyf, A., Luderer, H. F. et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocrine Rev. 29:726-776 doi:10.1210/er.2008-0004
139. Wasserman, R. H. (2004) Vitamin D and the dual processes of intestinal calcium absorption. J. Nutr. 134:3137-3139 PMID:15514288
140. Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J.-C. et al. (2013) Molecular mechanisms of vitamin D action. Calcif. Tissue Int. 92:77-98 doi:10.1007/s00223-012-9619-0
141. 2+ concentration. J. Biol. Chem. 273:33501-33507 doi:10.1074/jbc.273.50.33501
142. Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S. et al. (1998) Role of apoptosis in failure of β-cell mass compensation for insulin resistance and β-cell defects in the male Zucker diabetes fatty rat. Diabetes 47:358-364 doi:10.2337/diabetes.47.3.358
143. Donath, M. Y., Gross, D. J., Cerasi, E. and Kaiser, N. (1999) Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744 doi:10.2337/diabetes.48.4.738
144. 2+ current mediates cytokine-induced pancreatic β-cell death. Endocrinology 140:1200-1204 doi:10.1210/endo.140.3.6556
145. Rhodes, C. J. (2005) Type 2 diabetes - a matter of β-cell life and death? Science 307:380-384 doi:10.1126/science.1104345
146. Matsuoka, T. A., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y. et al. (1997) Glycation-dependent, reactive oxygen species mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest. 99:144-150 doi:10.1172/JCI119126
147. Ihara, Y., Toyokuni, S., Uchida, K., Odaka, H., Tanaka, T., Ikeda, H. et al. (1999) Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes. Diabetes 48:927-932 doi:10.2337/diabetes.48.4.927
148. Tanaka, Y., Gleason, C. E., Tran, P. O. T., Harmon, J. S. and Robertson, R. P. (1999) Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc. Natl Acad. Sci. U. S. A. 96:10857-10862 doi:10.1073/pnas.96.19.10857
149. Poitout, V. and Robertson, R. P. (2002) Minireview: secondary β-cell failure in type 2 diabetes - a convergence of glucotoxicity and lipotoxicity. Endocrinology 143:339-342 doi:10.1210/endo.143.2.8623
150. Tanaka, Y., Tran, P. O. T., Harmon, J. and Robertson, R. P. (2002) A role for glutathione peroxidase in protecting pancreatic β cells against oxidative stress in a model of glucose toxicity. Proc. Natl Acad. Sci. U. S. A. 99:12363-12368 doi:10.1073/pnas.192445199
151. Robertson, R. P. (2004) Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 279:42351-42354 doi:10.1074/jbc. R400019200
152. Fujimoto, S., Mukai, E. and Inagaki, N. (2011) Role of endogenous ROS production in impaired metabolism-secretion coupling of diabetic pancreatic β cells. Prog. Biophys. Mol. Biol. 107:304-310 doi:10.1016/j.pbiomolbio.2011.07.013
153. Gerber, P. A. and Rutter, G. A. (2016) The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxid. Redox Signal. doi:10.1089/ars.2016.6755
154. Grankvist, K., Marklund, S. L. and Täljedal, I. B. (1981) CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem. J. 199:393-398 doi:10.1042/bj1990393
155. Prentki, M. (1996) New insights into pancreatic β-cell metabolic signaling in insulin secretion. Eur. J. Endocrinol. 134:272-286 doi:10.1530/eje.0. 1340272
156. Evans, J. L., Goldfine, I. D., Maddux, B. A. and Grodsky, G. M. (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1-8 doi:10.2337/diabetes.52.1.1
157. Newsholme, P., Haber, E. P., Hirabara, S. M., Rebelato, E. L. O., Procopio, J., Morgan, D. et al. (2007) Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J. Physiol. 583:9-24 doi:10.1113/jphysiol.2007.135871
158. Calabrese, V., Cornelius, C., Leso, V., Trovato-Salinaro, A., Ventimiglia, B., Cavallaro, M. et al. (2012) Oxidative stress, glutathione status, sirtuin and cellular stress response in type 2 diabetes. Biochim. Biophys. Acta Mol. Basis Dis. 1822:729-736 doi:10.1016/j.bbadis.2011.12.003
159. 2+ signaling and disease. Cell Calcium 50:234-241 doi:10.1016/j.ceca.2011.05.011
160. Missiaen, L., Taylor, C. W. and Berridge, M. J. (1991) Spontaneous calcium release from inositol trisphosphate-sensitive calcium stores. Nature 352:241-244 doi:10.1038/352241a0
161. 2+ spikes in HeLa cells by sensitizing the inositol 1, 4, 5-trisphosphate receptor. J. Biol. Chem. 267:25113-25119
162. Bird, G. S., Burgess, G. M. and Putney, Jr, J. W. (1993) Sulfhydryl reagents and cAMP-dependent kinase increase the sensitivity of the inositol 1, 4, 5-trisphosphate receptor in hepatocytes. J. Biol. Chem. 268:17917-17923
163. Bánsághi, S., Golenár, T., Madesh, M., Csordás, G., RamachandraRao, S., Sharma, K. et al. (2014) Isoformand species-specific control of inositol 1, 4, 5-trisphosphate (IP3) receptors by reactive oxygen species. J. Biol. Chem. 289:8170-8181 doi:10.1074/jbc. M113.504159
164. 2+ leak in chronic heart failure. Circ. Res. 103:1466-1472 doi:10.1161/CIRCRESAHA.108.184457
165. Donoso, P., Sanchez, G., Bull, R. and Hidalgo, C. (2011) Modulation of cardiac ryanodine receptor activity by ROS and RNS. Front. Biosci. 16:553-567 doi:10.2741/3705
166. 2+ channels in endoplasmic reticulum stress and β-cell death. Diabetes 58:422-432 doi:10.2337/db07-1762
167. 2+ homeostasis in cultured aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 300, H493-H506 doi:10.1152/ajpheart.01073.2010
168. Mazahery, H., Camargo, Jr, C. A., Conlon, C., Beck, K. L., Kruger, M. C. and von Hurst, P. R. (2016) Vitamin D and autism spectrum disorder: a literature review. Nutrients 8:236 doi:10.3390/nu8040236
169. Dong, J. H., Wong, S. L., Lau, C. W., Lee, H. K., Ng, C. F., Zhang, L. H. et al. (2012) Calcitriol protects renovascular function in hypertension by downregulating angiotensin II type 1 receptors and reducing oxidative stress. Eur. Heart J. 33:2980-2990 doi:10.1093/eurheartj/ehr459
170. Briones, T. L. and Darwish, H. (2014) Decrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state. Neuroscience 262:143-155 doi:10.1016/j.neuroscience.2013.12.064
171. 3 regulates the synthesis of gamma-glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J. Neurochem. 73:859-866 doi:10.1046/j.1471-4159.1999.0730859.x
172. 3 against oxidative stress in nonmalignant human prostate epithelial cells. Int. J. Cancer 122:2699-2706 doi:10.1002/ijc.23460
173. Jain, S. K. and Micinski, D. (2013) Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem. Biophys. Res. Commun. 437:7-11 doi:10.1016/j.bbrc.2013.06.004ssss